Efficacy and Safety of Insulin Glargine 300 U/mL in People with Type 2 Diabetes Uncontrolled on Basal Insulin: The 26-Week Interventional, Single-Arm ARTEMIS-DM Study

被引：0
|
作者：
Bipin Sethi
Khalid Al-Rubeaan
Mustafa Unubol
Maria A. Mabunay
Baptiste Berthou
Valerie Pilorget
Shireene R. Vethakkan
Gustavo Frechtel
机构：
[1] Care Hospital,Faculty of Medicine
[2] Research and Scientific Center Sultan Bin Abdulaziz Humanitarian City,Hospital de Clínicas
[3] Aydın Adnan Menderes University,undefined
[4] IT&M Stats for Sanofi,undefined
[5] Sanofi,undefined
[6] University Malaya Medical Centre,undefined
[7] Universidad de Buenos Aires,undefined
来源：
Diabetes Therapy | 2022年 / 13卷
关键词：
Basal insulin; Glycaemic control; Hypoglycaemia; Insulin glargine 300 U/mL; Type 2 diabetes mellitus;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1395 / 1408
页数：13
相关论文
共 50 条
  • [1] Efficacy and Safety of Insulin Glargine 300 U/mL in People with Type 2 Diabetes Uncontrolled on Basal Insulin: The 26-Week Interventional, Single-Arm ARTEMIS-DM Study
    Sethi, Bipin
    Al-Rubeaan, Khalid
    Unubol, Mustafa
    Mabunay, Maria A.
    Berthou, Baptiste
    Pilorget, Valerie
    Vethakkan, Shireene R.
    Frechtel, Gustavo
    DIABETES THERAPY, 2022, 13 (07) : 1395 - 1408
  • [2] EFFICACY AND SAFETY OF INSULIN GLARGINE 300 U/ML IN PEOPLE WITH TYPE 2 DIABETES MELLITUS UNCONTROLLED ON BASAL INSULINS: ARTEMIS-DM STUDY
    Sethi, B.
    Al-Rubeaan, K.
    Unubol, M.
    Mabunay, M. A. N.
    Naqvi, M.
    Berthou, B.
    Pilorget, V.
    Frechtel, G.
    DIABETES TECHNOLOGY & THERAPEUTICS, 2022, 24 : A101 - A101
  • [3] Efficacy and Safety of Insulin Glargine 300 U/mL (Gla-300) in People with Type 2 Diabetes Mellitus (T2DM) Uncontrolled on Basal Insulins (BI): ARTEMIS-DM Study
    Sethi, Bipin
    Alrubeaan, Khalid
    Unubol, Mustafa
    Mabunay, Maria Aileen N.
    Naqvi, Mubarak
    Berthou, Baptiste
    Pilorget, Valerie
    Frechtel, Gustavo
    DIABETES, 2021, 70
  • [4] Efficacy and safety of switching to insulin glargine 300 U/mL in people with type 2 diabetes uncontrolled on basal insulin in China: A post hoc subpopulation analysis of the INITIATION study
    Chen, Liming
    Wan, Hailong
    Han, Jie
    Yang, Caixian
    Shao, Hailin
    Li, Jialin
    Yan, Wensheng
    Xiao, Jianzhong
    Sun, Yadong
    Li, Min
    Han, Yanfang
    Kang, Lei
    Zhang, Minlu
    DIABETES OBESITY & METABOLISM, 2025, 27 (03): : 1423 - 1431
  • [5] Efficacy and safety of insulin glargine 300 U/mL in people with type 2 diabetes in China: The INITIATION study
    Chen, Liming
    Wen, Binhong
    Liu, Haixia
    Wu, Hongmei
    Duan, Binhong
    Shu, Hongyan
    Zhang, Qiu
    Wu, Xiaohong
    Li, Min
    Han, Yanfang
    Kang, Lei
    Zhang, Minlu
    DIABETES OBESITY & METABOLISM, 2024, 26 (10): : 4571 - 4582
  • [6] TREATMENT SATISFACTION IN PEOPLE WITH T2D SWITCHED FROM BASAL INSULIN (BI) TO INSULIN GLARGINE 300 U/ML (GLA-300): PATIENT REPORTED OUTCOMES FROM ARTEMIS-DM STUDY
    Al-Rubeaan, K.
    Wilmot, E.
    Climens, A.
    Mabunay, M. A.
    Pilorget, V.
    Berthou, B.
    Frechtel, G.
    Sethi, B.
    DIABETES TECHNOLOGY & THERAPEUTICS, 2023, 25 : A130 - A130
  • [7] Efficacy and safety of a functionally selective insulin: a 26-week randomised, double blind trial versus insulin glargine in people with type 2 diabetes
    Heise, T.
    Haraldsson, H.
    Herbrand, T.
    Johansson, L.
    Jordan, J.
    Nishimura, E.
    Plum-Morschel, L.
    Tank, J.
    Thorisdottir, O.
    Lyby, K.
    DIABETOLOGIA, 2023, 66 (SUPPL 1) : S8 - S9
  • [8] Treatment Satisfaction in People with T2D Switched from Basal Insulin (BI) to Insulin Glargine 300 U/mL (Gla-300) : Patient-Reported Outcomes from ARTEMIS-DM Study
    Alrubeaan, Khalid
    Wilmot, Emma G.
    De Climens, Aude Roborel
    Mabunay, Maria Aileen N.
    Pilorget, Valerie
    Berthou, Baptiste
    Frechtel, Gustavo
    Sethi, Bipin
    DIABETES, 2022, 71
  • [9] Insulin glargine 300 U/mL for basal insulin therapy in type 1 and type 2 diabetes mellitus
    Lau, Ip Tim
    Lee, Ka Fai
    So, Wing Yee
    Tan, Kathryn
    Yeung, Vincent Tok Fai
    DIABETES METABOLIC SYNDROME AND OBESITY, 2017, 10 : 273 - 284
  • [10] Switching the basal insulin to insulin glargine 300 U/ml in people with type 2 diabetes under basal insulin supported oral therapy: Observational trial on effectiveness and safety
    Seufert, Jochen
    Wiesli, Peter
    Fritsche, Andreas
    Anderten, Helmut
    Pegelow, Katrin
    Pscherer, Stefan
    Pfohl, Martin
    DIABETES OBESITY & METABOLISM, 2022, 24 (01): : 72 - 81
12345